MICHAEL SCHMERTZLER

Profile

First Name

: MICHAEL

Middle Name

:

Last Name

: SCHMERTZLER

Related Companies
Titles
Company Name
Related People
DIRECTOR
SEGWAY INC
J. NORMAN ALLEN, BRIAN D. COHEN, JOHN DENNISTON, DEAN KAMEN, VERNON LOUCKS, JAMES NORROD
EXECUTIVE OFFICER, DIRECTOR
KOLLTAN PHARMACEUTICALS INC
ARTHUR G. ALTSCHUL, JR., ALEX BOLTE, AXEL BOLTE, STANLEY CHOY, YARON HADARI, JANE PRITCHETT HENDERSON, K. PETER HIRTH, PETER HIRTH, THERESA M. LAVALLEE, GERALD MCMAHON, PAUL MEDEIROS, W. BRADFORD MIDDLEKAUFF, THOMAS NEFF, THOMAS B. NEFF, JOSEPH SCHLESSINGER, CAROLYN F. SIDOR, E. JONATHAN SODERSTROM
DIRECTOR
PTC THERAPEUTICS, INC.
RICHARD ALDRICH, NEIL ALMSTEAD, NEIL ALMSTEAD, PH.D, WILLIAM BAIRD, III, AXEL BOLTE, MARK E. BOULDING, SOREN CARLSEN, CARL GOLDFISCHER, EMILY HILL, CLAUDIA HIRAWAT, ALLAN S. JACOBSON, ALLAN JACOBSON, PH.D., MATTHEW KLEIN, MATTHEW B. KLEIN, MATTHEW B. KLEIN, M.D., ADAM KOPPEL, MICHAEL KRANDA, GEOFFREY MCDONOUGH, LANGDON L. MILLER, LANGON L. MILLER, STEPANIE S. OKEY, STEPHANIE S. OKEY, DEEPA PAKIANATHAN, ERIC PAUWELS, STUART W. PELTZ, EMMA REEVE, MARY SMITH, DAVID P. SOUTHWELL, MARCIO SOUZA, GLENN D. STEELE JR., M.D., PH.D., GLENN D. STEELE, JR., PETER SVENNILSON, DAWN SVORONOS, CHRISTINE UTTER, ALETHIA YOUNG, JEROME B. ZELDIS, JEROME B. ZELDIS, M.D., PH.D.
DIRECTOR
SCHEDULICITY, INC.
JEFF BATTON, BRYON BENNETT, F. FOX, III BENTON, FOX BENTON, KEVIN NESSLAND, ANTHONY NETTUNO, JEROME NETTUNO, JERRY NETTUNO, MARC RANDOLPH, GREGORY ROGERS, JOSHUA SPITZER, SCOTT THORN, JEREMY WENOKUR
DIRECTOR
AGNOVOS BIOSCIENCE, INC.
JAMES BARRY, BILL BEASLEY, FALK DUKATZ, JASON FOLEY, CHRIS GEGEYLS, JAMES G. HOWE, JAMES T. HOWE, STEPHANIE KLADAKIS, ADAM LOWE, JAMES PILACHOWSKI, JAMES SHIMP, DAVID STILLER, ROBERT STILLER, DAWN SVORONOS, NICK VALERIANI, JARRETT WALDNER, ELLEN ZANE
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-03-12
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2023-12-20 
2023-06-09
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-26 
2023-05-08
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-04-10 
2020-06-12
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-05-29 
2020-05-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-04-29 
2018-09-05
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-08-23 
2013-05-15
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-05-14 
2013-03-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-03-07 
2013-02-12
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2013-01-29 
2012-06-13
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-05-29 
2012-03-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-01 
2011-02-16
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-05-04 
2010-09-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-01 
2010-01-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-29 
2009-12-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$25,000,001 - $100,000,000 
Equity 
2009-12-22 
2009-10-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$25,000,001 - $100,000,000 
 
2009-09-22 
2009-09-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-01 
2009-08-12
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2008-07-24 
2009-04-30
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-04-16